Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to permit the patients with schizophrenia who received
Sertindole during a previous randomised trial, study 99824, to continue with this treatment.